These findings are consistent with the results obtained from renal fibrosis [26], pulmonary fibrosis [27], and myocardial fibrosis [28], suggesting that antioxidant therapy can reduce the activation of NLRP3 inflammasome, thereby alleviating fibrosis of tissues and organs. This evidence concerns the gene NLRP3 and Myocardial fibrosis.